Rockefeller Capital Management L.P. Buys 37,636 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Rockefeller Capital Management L.P. boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 42.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 125,518 shares of the pharmacy operator’s stock after acquiring an additional 37,636 shares during the period. Rockefeller Capital Management L.P.’s holdings in Walgreens Boots Alliance were worth $6,603,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in WBA. Cullen Capital Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 5.6% during the 2nd quarter. Cullen Capital Management LLC now owns 2,599,729 shares of the pharmacy operator’s stock worth $136,772,000 after buying an additional 137,190 shares in the last quarter. Kingsview Wealth Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 201.7% during the 1st quarter. Kingsview Wealth Management LLC now owns 26,400 shares of the pharmacy operator’s stock worth $1,445,000 after buying an additional 17,649 shares in the last quarter. CIBC Asset Management Inc boosted its holdings in shares of Walgreens Boots Alliance by 5.1% during the 1st quarter. CIBC Asset Management Inc now owns 146,891 shares of the pharmacy operator’s stock worth $8,064,000 after buying an additional 7,177 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in shares of Walgreens Boots Alliance by 17.4% during the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 139,945 shares of the pharmacy operator’s stock worth $7,362,000 after buying an additional 20,782 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 1.8% during the 1st quarter. Geode Capital Management LLC now owns 11,415,810 shares of the pharmacy operator’s stock worth $624,920,000 after buying an additional 199,080 shares in the last quarter. Institutional investors and hedge funds own 55.65% of the company’s stock.

Shares of NASDAQ:WBA opened at $48.22 on Wednesday. The company has a market capitalization of $41.71 billion, a PE ratio of 18.27, a price-to-earnings-growth ratio of 1.41 and a beta of 0.49. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.77 and a quick ratio of 0.53. The business has a fifty day moving average price of $48.20 and a two-hundred day moving average price of $51.26. Walgreens Boots Alliance, Inc. has a 1 year low of $33.36 and a 1 year high of $57.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Wednesday, June 30th. The pharmacy operator reported $1.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.21. The firm had revenue of $34.03 billion during the quarter, compared to the consensus estimate of $33.47 billion. Walgreens Boots Alliance had a return on equity of 20.79% and a net margin of 1.66%. The business’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.71 EPS. Sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.75 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, September 10th. Stockholders of record on Friday, August 20th were paid a dividend of $0.477 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.47. The ex-dividend date was Thursday, August 19th. This represents a $1.91 annualized dividend and a dividend yield of 3.96%. Walgreens Boots Alliance’s dividend payout ratio is presently 40.30%.

A number of equities analysts have issued reports on the company. TheStreet cut Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a report on Friday, June 18th. Truist lowered their target price on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a research report on Friday, July 2nd. Deutsche Bank Aktiengesellschaft lowered their target price on Walgreens Boots Alliance from $55.00 to $52.00 and set a “hold” rating on the stock in a research report on Friday, July 2nd. Evercore ISI reaffirmed a “hold” rating and set a $52.00 target price on shares of Walgreens Boots Alliance in a research report on Friday, July 2nd. Finally, Credit Suisse Group lowered their target price on Walgreens Boots Alliance from $50.00 to $48.00 and set a “neutral” rating on the stock in a research report on Friday, July 2nd. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $50.83.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

Featured Story: Federal Reserve

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.